Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 197,433,024
  • Shares Outstanding, K 1,734,455
  • Annual Sales, $ 40,109 M
  • Annual Income, $ 5,723 M
  • EBIT $ 8,588 M
  • EBITDA $ 11,831 M
  • 60-Month Beta 0.73
  • Price/Sales 4.80
  • Price/Cash Flow 17.83
  • Price/Book 4.92

Options Overview Details

View History
  • Implied Volatility 24.16% ( +0.30%)
  • Historical Volatility 12.09%
  • IV Percentile 84%
  • IV Rank 65.42%
  • IV High 29.56% on 10/08/24
  • IV Low 13.95% on 11/27/24
  • Put/Call Vol Ratio 2.90
  • Today's Volume 17,763
  • Volume Avg (30-Day) 8,411
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 201,876
  • Open Int (30-Day) 209,983

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.34
  • Number of Estimates 9
  • High Estimate 1.34
  • Low Estimate 1.33
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +12.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
111.28 +1.58%
on 12/19/24
116.39 -2.88%
on 12/10/24
-2.56 (-2.21%)
since 12/06/24
3-Month
111.28 +1.58%
on 12/19/24
121.00 -6.58%
on 11/06/24
+0.40 (+0.36%)
since 10/04/24
52-Week
99.71 +13.37%
on 07/18/24
121.64 -7.07%
on 03/08/24
+2.24 (+2.02%)
since 01/05/24

Most Recent Stories

More News
2 No-Brainer Dividend Stocks to Buy With $250 in 2025

When it comes to dividend investing, there are two basic paths you can take. You could seek out businesses that are raising their payouts at a rapid pace, but these stocks tend to offer low yields. The...

ABT : 113.04 (-0.69%)
ABBV : 180.10 (-0.62%)
WPC : 54.93 (+0.15%)
EXR : 148.56 (-1.64%)
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

If you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Having to spend more just to maintain their current standard of living is a constant...

ABT : 113.04 (-0.69%)
ABBV : 180.10 (-0.62%)
MDT : 79.84 (-1.37%)
BMY : 56.68 (+0.19%)
Earnings Preview: What to Expect From Abbott's Report

Abbott will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

ABT : 113.04 (-0.69%)
XLV : 139.02 (+0.04%)
$SPX : 5,975.38 (+0.55%)
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years

Want some solid dividend growth stocks with incredible track records of increasing their payouts? Here's a list of stocks that have been raising their dividend payments consistently for more than 50 consecutive...

TGT : 139.29 (+2.58%)
ABT : 113.04 (-0.69%)
HRL : 30.68 (-2.17%)
WMT : 91.43 (+0.72%)
5 MedTech Stocks That Are Poised to Beat the Market in 2025

The MedTech industry has demonstrated resilience and growth throughout 2024 despite enduring persistent challenges such as supply chain disruptions, regulatory hurdles, and the need to adapt to rapidly...

ABT : 113.04 (-0.69%)
SYK : 361.36 (-0.04%)
BSX : 91.29 (+0.66%)
ALGN : 218.88 (+5.10%)
ISRG : 542.37 (+1.32%)
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

A few different elements can make a stock a no-brainer buy. The company could be the leader in its market, or well diversified across various markets. In any case, it should have a solid track record of...

ABT : 113.04 (-0.69%)
ISRG : 542.37 (+1.32%)
Is Abbott Stock Worth Buying at a Discounted P/S Valuation?

Like all its peers, Abbott Laboratories ABT faced the industrywide challenges of margin pressure through 2024, stemming from growing inflation, labor shortages and supply chain disruptions, which increased...

ABT : 113.04 (-0.69%)
BSX : 91.29 (+0.66%)
MDT : 79.84 (-1.37%)
Introducing the "Dividend Seven" Stocks

In this podcast, Motley Fool analysts Matt Argersinger and Anthony Schiavone join host Mary Long to discuss:

BLK : 1,012.74 (-0.79%)
META : 630.20 (+4.23%)
NVDA : 149.43 (+3.43%)
C : 72.74 (+2.45%)
BAC : 45.40 (+1.32%)
KO : 60.81 (-1.52%)
JPM : 240.85 (-0.49%)
PLD : 106.66 (+0.98%)
ABBV : 180.10 (-0.62%)
GS : 583.39 (+0.56%)
MCD : 292.18 (-0.88%)
HSY : 166.74 (-1.35%)
Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

ABT : 113.04 (-0.69%)
$SPX : 5,975.38 (+0.55%)
PFE : 26.89 (+1.13%)
My Top 10 Stocks to Buy for 2025

It's that time of year again. I'm not referring to buying gifts and preparing holiday meals -- although that may be part of your agenda too. It's time to look back on your portfolio's performance and plan...

NVDA : 149.43 (+3.43%)
VKTX : 42.53 (-0.84%)
CRWD : 366.36 (+2.04%)
ABT : 113.04 (-0.69%)
ETSY : 56.61 (+5.03%)
VRTX : 402.49 (-1.13%)
AXP : 301.88 (-0.40%)
AMZN : 227.61 (+1.53%)
PFE : 26.89 (+1.13%)
PLTR : 75.92 (-4.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 115.41
2nd Resistance Point 114.84
1st Resistance Point 113.94
Last Price 113.04
1st Support Level 112.46
2nd Support Level 111.89
3rd Support Level 110.99

See More

52-Week High 121.64
Fibonacci 61.8% 113.26
Last Price 113.04
Fibonacci 50% 110.68
Fibonacci 38.2% 108.09
52-Week Low 99.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar